profit from every $100 of sales.
$0$100
Picard Medical
$7.23-7.90% today
+196.3% in 1 year
1-year low $0.961-year high $86.50
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Picard Medical sold, what it kept, and what it did with the cash.
Sales went from $4.11 million in 2022 to $4.94 million in 2025, with -$27.0 million of profit last year.
SalesProfit
Picard Medical vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Picard Medical | No profit yet | ||
 Boston Scientific | 22.2× · Fair price | ||
 Koninklijke Philips | 30.1× · Expensive | ||
 Steris | 32.8× · Expensive | ||
 Zimmer Biomet Holdings | 27.7× · Fair price |
AI analysis
An AI analyst reads Picard Medical's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 4 | 5 | 4 | 5 | |
| -5 | -2 | -0 | -0 | |
| -11 | -16 | -14 | -13 | |
| -11 | -15 | -17 | -21 | |
| -11 | -16 | -21 | -27 | |
| -0.18 | -0.25 | -0.33 | -0.75 | |
| -121.3% | -45.8% | -2.6% | -4.1% | |
| -269.1% | -307.4% | -312.3% | -268.4% | |
| -271.5% | -308.7% | -479.5% | -546.6% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 15 | 11 | 12 | 23 |
| Cash | 0 | 0 | 0 | 7 |
| Total debt | 2 | 9 | 21 | 7 |
| Total liabilities | 4 | 15 | 36 | 19 |
| 11 | -4 | -24 | 4 | |
| 72 | 72 | 72 | 36 | |
| -66.1% | -208.1% | – | -158.3% | |
| -98.2% | 438.3% | 88.7% | -712.6% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -11 | -11 | -12 | -16 | |
| 0 | 0 | – | – | |
| -11 | -11 | -12 | -16 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 0 | 0 | 1 | 1 |
Valuation
- –
- –
- –
- -8.2×
- 3.6×
- –
- –
- -88.2%
- -151.9%
- 0.0%
Profitability
- -4.1%
- -268.4%
- -546.6%
- -349.2%
- -1,249.1%
- 37.3%
- 499.2%
- -266.1%
- 977.4%
- 74.6%
Growth
- +6.3%
- –
- −32.0%
- –
- +0.8%
Financial health
- -0.0×
- -1.78
- 22.9%
- -2.9×
- 0.75
- 0.16
- 0.49
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 35%of 886
Bottom 1%of 987
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 15, 2026 | -0.10 | -0.10 | +0.0% |
| Mar 25, 2026 | -0.06 | – | – |
| Nov 14, 2025 | -0.19 | – | – |
| Sep 11, 2025 | -0.85 | – | – |
News
Japan services PMI rises to 51.7 in October; composite growth slows to 5-month lowSeeking Alpha · Nov 5, 2026Australian services PMI hits 7-month low of 48.5; Ai Group manufacturing index plungesSeeking Alpha · Nov 4, 2026China’s services PMI misses expectations at 50.8 in October, composite PMI drops to 52.0Seeking Alpha · Nov 4, 2026RatingDog China PMI beats forecast at 52.0; official NBS manufacturing drops to 49.3Seeking Alpha · Nov 2, 2026Eurozone economic growth picks up speed as PMI climbs to 41-month highSeeking Alpha · Sep 23, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/5Passes 0 of 5. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
34No pass
Benjamin Graham
7No pass
Philip Fisher
38No pass
Peter Lynch
–Not enough data
Joel Greenblatt
–Not enough data
Charlie Munger
42No pass
Terry Smith
37No pass
Questions about Picard Medical
Is Picard Medical a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 5 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Picard Medical AI analysis
What does Picard Medical do?
Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. It is in Medical - Devices.
Does Picard Medical pay a dividend?
No. Picard Medical does not pay a dividend at the moment.
Is Picard Medical stock halal?
No. Picard Medical does not pass our halal screen: its debt is 39% of its market value, at or above the 33% limit. How we check
How has Picard Medical stock done over the past year?
Up 196.3% over the past twelve months, to $7.23. It traded between $0.96 and $86.50 and is 91.6% below its high.
Who are Picard Medical's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Picard Medical's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.